GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Haleon PLC (NYSE:HLN) » Definitions » Other Net Income (Loss)

Haleon (Haleon) Other Net Income (Loss) : $0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Haleon Other Net Income (Loss)?

Haleon's Other Net Income (Loss) for the three months ended in Mar. 2024 was $0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 was $0 Mil.

Haleon's quarterly Other Net Income (Loss) declined from Sep. 2023 ($0 Mil) to Dec. 2023 ($-0 Mil) but then increased from Dec. 2023 ($-0 Mil) to Mar. 2024 ($0 Mil).

Haleon's annual Other Net Income (Loss) declined from Dec. 2021 ($0 Mil) to Dec. 2022 ($-0 Mil) but then stayed the same from Dec. 2022 ($-0 Mil) to Dec. 2023 ($-0 Mil).


Haleon Other Net Income (Loss) Historical Data

The historical data trend for Haleon's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Haleon Other Net Income (Loss) Chart

Haleon Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Other Net Income (Loss)
- - - - -

Haleon Quarterly Data
Dec19 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Net Income (Loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Haleon Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Haleon Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Haleon's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.


Haleon (Haleon) Business Description

Traded in Other Exchanges
Address
The Heights, Building 5, First Floor, Surrey, Weybridge, GBR, KT13 0NY
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.